HCW Biologics removes equity-plan proposal, reschedules special meeting
The company said it will remove Proposal No. 2, an amended performance-based equity plan, from its preliminary proxy. It also said it will reschedule the special meeting.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.